National Space Biomedical Research Institute Report issue

Government Phase 3 Phase 4

Organization Overview

First Clinical Trial
2009
NCT00968344
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

National Space Biomedical Research Institute

Active Ingredients

Drugs in Phase 4 Trials (1)

promethazine hydrochloride (phenergan) (1 trial)

Drugs in Phase 3 Trials (1)

leucine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Motion Sickness (Phase 4)

Space Motion Sickness (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2